QuantumSi Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

QuantumSi Stock Summary

QuantumSi competes with Nurix Therapeutics, Seer, HCW Biologics, MediciNova, and Beam Therapeutics. Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut. Quantum Si operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 153 people.

QuantumSi Key Financial Ratios

QuantumSi Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining QuantumSi's current stock value. Our valuation model uses many indicators to compare QuantumSi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across QuantumSi competition to find correlations between indicators driving QuantumSi's intrinsic value. More Info.QuantumSi is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, QuantumSi's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the QuantumSi's earnings, one of the primary drivers of an investment's value.

QuantumSi Systematic Risk

Today, most investors in QuantumSi Stock are looking for potential investment opportunities by analyzing not only static indicators but also various QuantumSi's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of QuantumSi growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of QuantumSi help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of QuantumSi. We use our internally-developed statistical techniques to arrive at the intrinsic value of QuantumSi based on widely used predictive technical indicators. In general, we focus on analyzing QuantumSi Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build QuantumSi's daily price indicators and compare them against related drivers.

When running QuantumSi's price analysis, check to measure QuantumSi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuantumSi is operating at the current time. Most of QuantumSi's value examination focuses on studying past and present price action to predict the probability of QuantumSi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuantumSi's price. Additionally, you may evaluate how the addition of QuantumSi to your portfolios can decrease your overall portfolio volatility.